Laparoscopic surgery has been adopted in some parts of the world as an innovative approach to the resection of gastric cancers. However, in the modern era of surgical oncology, to overcome intrinsic limitations of the traditional laparoscopy, the robotic approach is advocated as able to facilitate the lymph node dissection and complex reconstruction after gastrectomy, to assure oncologic safety also in advanced gastric cancer patients. Previous meta-analyses highlighted a lower complication rate as well as bleeding in the robotic approach group when compared to the laparoscopic one. This potential benefit must be balanced against an increased time of intervention. The aim of this umbrella review is to provide a comprehensive overview of the literature for surgeons and policymakers in order to evaluate the potential benefits and harms of robotic gastrectomy compared with the laparoscopic approach for gastric cancer. Methods and analysis: We will perform a comprehensive search of the PubMed, Cochrane, Embase databases and reference list of relevant publications for systematic review and meta-analyses comparing the outcomes of robotic gastrectomy (RG) and laparoscopic gastrectomy (LG) in patients with gastric cancer. Studies will be selected by two independent reviewers based on prespecified eligibility criteria and the quality will be assessed according to AMSTAR (A MeaSurement Tool to Assess systematic Reviews) checklist. All information will be collected using piloted and standardized data extraction forms in DistillerSR developed following the Joanna Briggs Institute's recommended extraction items. Ethics and dissemination: This umbrella review will inform clinical and policy decisions regarding the benefits and harms of robotic gastrectomy for treating gastric cancer. The results will be disseminated through a peer-reviewed publication, conference presentations and the popular press. Formal ethical approval is not required as primary data will not be collected. PRSOPERO registration number: International Prospective Register for Systematic Reviews (PROSPERO) number CRD.
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Other than as permitted in any relevant BMJ Author' meet the same success and is currently available only in high-volume centers. Technical difficulties due to total gastrectomy procedure as well as D2 lymphadenectomy, entailing the removal of node stations along the celiac trunk, left gastric artery and hepatic pedicle, are advocated as limiting factor of laparoscopic surgery diffusion [13, 14] . In the modern era of surgical oncology, to overcome some intrinsic limitations of the traditional laparoscopy, robotic approach is advocated by some authors as able to facilitate complex reconstruction after gastrectomy and the lymph node dissection, so as to assure oncologic safety also in advanced gastric cancer patients [15] [16] [17] . Since the first report of robotic gastrectomy by Hashizume et al in 2003 [18] , many observational studies have reported the effectiveness and safety of RG [19] [20] [21] [22] [23] . Previous meta-analyses [24] [25] [26] highlighted a lower complication rate as well as bleeding in the robotic approach group when compared to the laparoscopic one. This potential benefit must be balanced against an increased time of intervention. Surgeons and policymakers require a comprehensive overview of the depth and strength of the scientific evidence in order to evaluate the potential benefits and harms associated with the robotic gastrectomy for gastric cancer. To this end, we will perform a comprehensive umbrella review to collect and assess information from previous systematic reviews that have compared the laparoscopic with robotic gastrectomy. We will seek to answer the following question using the findings of highquality systematic reviews: What are the benefits and harms of robotic gastrectomy compared with laparoscopic approach? Umbrella reviews are syntheses of existing systematic reviews and/or metaanalyses providing an ideal method to comprehensively review the evidence base and to explore the contradictory findings of previous reviews [27] . Since a number of previous systematic reviews on this topic are available and timely evidence is required to inform scientific community, undertaking a de novo systematic review would not be appropriate. An umbrella review design will allow us to explore the reasons for discrepant findings in previous systematic reviews and to provide clinicians and policymakers with evidence in a timely manner.
Methods and analysis
This umbrella review was designed using the methodology guidelines for umbrella reviews provided by the Joanna Briggs Institute [27] . As well, we followed the Preferred Reporting Items for Systematic review and Meta-Analyses (PRISMA) guidelines and the extension for protocols [28] . This protocol is registered with PROSPERO (no.).
Search strategy
We will search for systematic review and meta-analysis comparing the outcomes of robotic gastrectomy (RG) and laparoscopic gastrectomy (LG) in patients with gastric cancer. A literature search will be conducted in PubMed, Cochrane and Embase databases for all articles published up to May 2019 with the Medical Subject Headings (MeSH) and keywords "gastrectomy", "gastric cancer", "gastric adenocarcinoma", "robotic", "laparoscopic", Systematic reviews". The key words will be used in all possible combinations to obtain the maximum number of articles. The "related article" function from PubMed will be used to further identify potential articles that were eligible for inclusion in the review. The bibliography of all selected articles will be hand searched to identify additional articles that met our inclusion criteria.
Inclusion criteria
We set the inclusion criteria for this umbrella review according the PICO (population, intervention, context, outcome) format [29] : 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Intervention: Robotic total/subtotal gastrectomy with curative intent.
Comparison: Laparoscopic total/subtotal gastrectomy with curative intent.
Outcomes: The primary outcome of interest will be the short-term outcomes of robotic surgery compared with laparoscopic approach in terms of operation time, blood loss, number of harvested lymph nodes and length of hospital stay. Additionally, overall survival for patients submitted to robotic approach compared to laparoscopic approach will be a secondary aim.
All outcomes will be assessed based on the definitions applied in the selected meta-analyses. Studies will not be included or excluded on the basis of reported outcomes.
Study designs
Systematic evidence syntheses that included retrospective as well as prospective studies compared different surgical outcomes following robotic or laparoscopic gastrectomy will be eligible for inclusion. To be eligible for inclusion, studies must be adhered to a systematic process to the literature search and study selection. Studies must report the data separately for the robotic and laparoscopic groups. Only meta-analyses in English language will be used during the screening or study selection process.
Study selection
The eligibility criteria will be applied to each title and abstract identified in the literature search by two independent reviewers (LM and DF) in a standardized procedure. All records identified by at least one author as potentially relevant will be obtained in full-text format. The eligibility criteria will then be applied to the full-text records, and a final decision will be made for inclusion. Conflicts will be resolved by discussion.
Quality assessment
Two independent reviewers (LM and DF) will assess the quality of the included studies using the appropriate AMSTAR (A MeaSurement Tool to Assess systematic Reviews) [30] checklist, and any disagreements will be resolved by consensus. Any included reviews that do not meet these minimum requirements will remain excluded: use of a comprehensive search strategy involving two or more electronic databases; use of an explicit statement describing the inclusion criteria applied to patient groups; use of a formal critical appraisal or quality assessment process for all included studies and report the outcome of that process; report findings on outcomes of interest using details on the study and patient characteristics of two or more studies and provide the direction of the findings from any pooled analyses (narrative or meta-analysis) carried out, including direction of effect and any statistical significance. In the event that included reviews report significantly overlapping lists of included studies reporting the same outcome(s), we will report findings from every studies.
Data collection
Data were extracted by two authors, who independently reviewed and screened all eligible studies for content according to the inclusion criteria above indicated. Any disagreements will be resolved by consensus when possible; otherwise, the judgement of a third reviewer will be considered final. Data recorded included: study design, review method, country of origin, year of publication, sample size, demographic features, clinicopathological characteristics, total number of patients assessed in survival analysis, total number of retrieved lymph nodes, median or mean duration of follow-up, and overall survival outcomes. We will extract the effect estimates for the outcomes of interest for the whole population, as well as the method of synthesis (eg, meta-analysis, network meta-analysis). The authors' overall conclusion or recommendation will also be extracted. All informations will be collected using piloted and standardized data abstraction forms in DistillerSR, an online systematic review software. Extraction forms will be developed following the Joanna Briggs Institute's recommended extraction items [27] .
Data summary
The aim of this umbrella review is to present a summary of the existing research syntheses addressing the comparison between RG and LG for gastric cancer. The findings will be summarized from the most recent high-quality systematic reviews using a narrative approach. A tabular summary of review characteristics (year of publication, country of origin, number of included studies, setting and/or context and interventions) will be provided. Outcome data will be summarized with respect to the number of included studies, number of participants, effect estimates and heterogeneity. Strengths and limitations of the included studies, as assessed by AMSTAR, will also be presented.
Dissemination
In this umbrella review we will undertake a comprehensive overview of the literature in order to evaluate the potential benefits and harms of robotic gastrectomy compared with the laparoscopic approach for gastric cancer. The results of our review will be of interest to surgeons and policymakers. Our data will be disseminated through a peer-reviewed publication, conference presentations and the popular press. Formal ethical approval is not required as primary data will not be collected. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
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Aim
Surgeons and policymakers require a comprehensive overview of the depth and strength of the scientific evidence in order to evaluate the potential benefits and harms associated with the robotic gastrectomy for gastric cancer. To this end, we will perform a comprehensive umbrella review to collect and assess information from previous systematic reviews that have compared the laparoscopic with robotic gastrectomy. We will seek to answer the following question using the findings of highquality systematic reviews: What are the benefits and harms of robotic gastrectomy compared with laparoscopic approach? Umbrella reviews are syntheses of existing systematic reviews and/or metaanalyses providing an ideal method to comprehensively review the evidence base and to explore the contradictory findings of previous reviews [27] . Since a number of previous systematic reviews on this topic are available and timely evidence is required to inform scientific community, undertaking a de novo systematic review would not be appropriate. An umbrella review design will allow us to explore the reasons for discrepant findings in previous systematic reviews and to provide clinicians and policymakers with evidence in a timely manner.
Methods and analysis
This umbrella review was designed using the methodology guidelines for umbrella reviews provided by the Joanna Briggs Institute [27] . As well, we followed the Preferred Reporting Items for Systematic review and Meta-Analyses (PRISMA) guidelines and the extension for protocols [28] . This protocol is registered with PROSPERO (no. CRD42019139906).
Search strategy
We will search for systematic review and meta-analysis comparing the outcomes of robotic gastrectomy (RG) and laparoscopic gastrectomy (LG) in patients with gastric cancer. A literature search will be conducted in PubMed, Cochrane and Embase databases for all articles published up to May 2019 with the Medical Subject Headings (MeSH) and keywords "gastrectomy", "gastric cancer", "gastric adenocarcinoma", "robotic", "laparoscopic", Systematic reviews". The key words will be used in all possible combinations to obtain the maximum number of articles. The "related article" function from PubMed will be used to further identify potential articles that were eligible for inclusion in the review. The bibliography of all selected articles will be hand searched to identify additional articles that met our inclusion criteria. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 We set the inclusion criteria for this umbrella review according the PICO (population, intervention, context, outcome) format [29] :
Inclusion criteria
Population: Adult patients with diagnosis of resectable gastric cancer.
Intervention: Robotic total/subtotal gastrectomy with curative intent.
Study designs
Study selection
Quality assessment
Two independent reviewers (LM and DF) will assess the quality of the included studies using the appropriate AMSTAR (A MeaSurement Tool to Assess systematic Reviews) [30] checklist, and any disagreements will be resolved by consensus. Any included reviews that do not meet these minimum requirements will remain excluded: use of a comprehensive search strategy involving two or more electronic databases; use of an explicit statement describing the inclusion criteria applied to patient groups; use of a formal critical appraisal or quality assessment process for all included studies and report the outcome of that process; report findings on outcomes of interest using details on the study and patient characteristics of two or more studies and provide the direction of the findings from any pooled analyses (narrative or meta-analysis) carried out, including direction of effect and any statistical significance. In the event that included reviews report significantly overlapping lists of included studies reporting the same outcome(s), we will report findings from every studies. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Data were extracted by two authors, who independently reviewed and screened all eligible studies for content according to the inclusion criteria above indicated. Any disagreements will be resolved by consensus when possible; otherwise, the judgement of a third reviewer will be considered final. Data recorded included: study design, review method, country of origin, year of publication, sample size, demographic features, clinicopathological characteristics, total number of patients assessed in survival analysis, total number of retrieved lymph nodes, median or mean duration of follow-up, and overall survival outcomes. We will extract the effect estimates for the outcomes of interest for the whole population, as well as the method of synthesis (eg, meta-analysis, network meta-analysis). The authors' overall conclusion or recommendation will also be extracted. All informations will be collected using piloted and standardized data abstraction forms in DistillerSR, an online systematic review software. Extraction forms will be developed following the Joanna Briggs Institute's recommended extraction items [27] .
Data collection
Data summary
Patient and Public Involvement
Patients and or public were not involved for this study protocol.
Dissemination
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METHODS
Eligibility criteria 8 Specify the study characteristics (such as PICO, study design, setting, time frame) and report characteristics (such as years considered, language, publication status) to be used as criteria for eligibility for the review 5-6
Information sources 9 Describe all intended information sources (such as electronic databases, contact with study authors, trial registers or other grey literature sources) with planned dates of coverage 5
Search strategy 10 Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be repeated 6 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46 F o r p e e r r e v i e w o n l y Study records: Data management 11a Describe the mechanism(s) that will be used to manage records and data throughout the review 6
Selection process 11b State the process that will be used for selecting studies (such as two independent reviewers) through each phase of the review (that is, screening, eligibility and inclusion in meta-analysis) 6
Data collection process 11c Describe planned method of extracting data from reports (such as piloting forms, done independently, in duplicate), any processes for obtaining and confirming data from investigators 7-8
Data items 12 List and define all variables for which data will be sought (such as PICO items, funding sources), any pre-planned data assumptions and simplifications Outcomes and prioritization 13 List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale 6-8
Risk of bias in individual studies
14 Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis 8
15a Describe criteria under which study data will be quantitatively synthesised 8 15b If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data and methods of combining data from studies, including any planned exploration of consistency (such as I 2 , Kendall's τ) 8
15c Describe any proposed additional analyses (such as sensitivity or subgroup analyses, meta-regression) 8
Data synthesis
15d If quantitative synthesis is not appropriate, describe the type of summary planned 8 Meta-bias(es) 16 Specify any planned assessment of meta-bias(es) (such as publication bias across studies, selective reporting within studies) 9
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